FAQ/Help |
Calendar |
Search |
Today's Posts |
09-02-2016, 04:55 PM | #1 | ||
|
|||
Member
|
|
||
Reply With Quote |
09-03-2016, 01:21 AM | #2 | ||
|
|||
Member
|
"The promising effects of Aducanumab are currently being investigated in two large phase three clinical studies to further evaluate safety and efficacy. Involving over 300 centers in 20 countries throughout North America, Europe, and Asia, these studies are evaluating the effectiveness and safety of the antibody on a total of 2,700 patients with early-stage Alzheimer's disease."
https://www.sciencedaily.com/release...0831133555.htm They will be in a better position to make a judgement after these studies have been completed. |
||
Reply With Quote |
"Thanks for this!" says: | soccertese (09-03-2016) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Could genetically modified WORMS help CURE Alzheimer's and Parkinson's disease? - Exp | Parkinson's News | |||
Doctor says, 'I think we're going to cure Alzheimer's disease, and we're not far away | Parkinson's Disease |